LRRC63: A Protein Structure and Function Study (G220416)

Target Name: LRRC63

NCBI ID: G220416

LRRC63

LRRC63: A Protein Structure and Function Study

Proteins are the building blocks of life, and their diverse structure and function contribute to the complexity and diversity of living organisms. One class of proteins is known as Leucine-rich repeat (LRRC) proteins, which are characterized by a specific repeat sequence composed of leucine amino acids. LRRC63 is a protein that belongs to this family and has been identified as a potential drug target or biomarker.

Structure and Function

The LRRC63 protein is 19 kilodalton in size and has a unique structure that consists of a long N-terminus, a single transmembrane region, and a C-terminus. The protein is rich in leucine amino acids, which are known for their ability to interact with various signaling molecules and contribute to protein function.

The LRRC63 protein has a characteristic LRRC repeat sequence that is composed of six continuous leucine amino acids. The repeat sequence is located at the N-terminus of the protein and is responsible for the protein's unique structure and function. The LRRC repeat sequence functions as a binding site for small molecules, such as drugs, peptides, and proteins, which can interact with the protein and modulate its activity.

The LRRC63 protein is involved in various cellular processes, including cell signaling, protein-protein interactions, and DNA replication. It is a key regulator of the cell cycle, and its levels have been shown to be regulated by various factors, including growth conditions, hormonal signals, and stress.

LRRC63 has also been shown to play a role in the regulation of cell adhesion and migration. The protein is involved in the formation of tight junctions, which are critical for maintaining tissue structure and function, and has been shown to interact with the protein JNK1.

LRRC63 has also been shown to contribute to the regulation of DNA replication and repair. The protein is involved in the recruitment of the DNA replication complex to the site of a DNA damage, and has been shown to interact with the protein HDAC1.

LRRC63 has also been shown to play a role in the regulation of cell signaling pathways, including the TGF-β pathway. The protein is involved in the regulation of the activity of the transcription factor TGF-β1, and has been shown to interact with the protein FGF1.

Drugs and Peptides

The LRRC63 protein is a potential drug target due to its unique structure and function. Several small molecules have been shown to interact with the LRRC63 protein and have been identified as potential drug candidates. One such molecule is the peptide GLT-1, which consists of the first 11 amino acids of the LRRC63 protein. GLT-1 has been shown to interact with the LRRC63 protein and has been shown to enhance the activity of the protein in cell signaling pathways.

Another potential drug candidate is the small molecule drugletisin, which is a derivative of the drugletisin A, a natural product that has been shown to have anticancer and anti-inflammatory effects. The drugletisin derivative has been shown to interact with the LRRC63 protein and has been shown to enhance the activity of the protein in cell signaling pathways.

Conclusion

LRRC63 is a protein that has unique structure and function due to its LRRC repeat sequence. The protein is involved in various cellular processes, including cell signaling, protein-protein interactions, and DNA replication. It is a potential drug target due to its unique structure and function, and several small molecules have been shown to interact with the protein. Further research is needed to fully understand the role of LRRC63 in cellular processes and its potential as a drug target.

Protein Name: Leucine Rich Repeat Containing 63

The "LRRC63 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC63 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets